Viral Inactivation Industry Forecast to Hit $8.24 Billion by 2029 With a Strong 10.8% CAGR

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

#What Are The Current (2025) And Forecast (2029) Sizes Of The Viral Inactivation Market?

The viral inactivation market size has seen substantial growth in recent years. Projections indicate it will increase from $5.01 billion in 2024 to $5.47 billion in 2025, at a compound annual growth rate (CAGR) of 9.2%. The historical growth can be attributed to several factors including global air traffic growth, enhanced navigation capabilities, commercial aviation expansion, airline cost savings, improved flight safety, and a reduction in pilot workload.

The viral inactivation market is poised for significant expansion over the coming years, with projections indicating it will reach $8.24 billion in 2029, growing at a compound annual growth rate (CAGR) of 10.8%. This anticipated growth is largely driven by factors such as the development of autonomous flight, advancements in next-generation aircraft designs, ongoing efforts toward sustainable aviation, the emergence of urban air mobility (UAM), and an increasing overall demand for aircraft. During this forecast period, major trends are expected to include the integration of advanced avionics, the widespread implementation of artificial intelligence, innovations in human-machine interfaces (HMI), the retrofitting of existing aircraft, and the enhanced integration of global navigation satellite systems (GNSS).

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=10401&type=smp

Which Major Market Drivers Are Shaping The Future Of The Viral Inactivation Market?

The viral inactivation market is expected to grow in the future due to the increasing prevalence of various infectious diseases. Infectious diseases are conditions that can be transmitted from one person to another through contaminated food and beverages, or via pathogens such as viruses, bacteria, fungi, and parasites. Viral inactivation is widely employed in human disease control programs to neutralize viruses using physical and chemical disinfectants, thereby preventing the spread of contagious viral infections and driving the growth of the viral inactivation market. For instance, in March 2024, the Centers for Disease Control and Prevention, a US-based national public health agency, reported an increase in tuberculosis cases from 8,320 in 2022 to 9,615 in 2023, representing a rise of 1,295 cases. The associated rate also increased from 2.5 per 100,000 persons in 2022 to 2.9 in 2023. Therefore, the expanding instances of diverse infectious diseases are propelling the expansion of the viral inactivation market.

What Are The Major Segment Types Covered In The Viral Inactivation Market?

The viral inactivationmarket covered in this report is segmented –

1) By Product: Kits And Reagents; Systems; Services

2) By Method: Solvent Detergent Method; pH Adjustment Method; Pasteurization; Other Methods

3) By Application: Vaccines And Therapeutics; Tissues And Tissue Products; Blood And Blood Products; Other Applications

4) By End User: Pharmaceutical And Biotechnology Companies; Contract Research Organizations; Blood Banks; Hospital; Academic Research Institutes; Other End Users

Subsegments:

1) By Kits And Reagents: Viral Inactivation Kits; PCR Reagents; Antibodies and Enzymes

2) By Systems: Automated Viral Inactivation Systems; Batch Viral Inactivation Systems; Continuous Flow Systems

3) By Services: Viral Testing Services; Validation Services; Consulting Services

Which Market Trends Are Creating New Opportunities In The Viral Inactivation Industry?

The viral inactivation market is witnessing a significant trend toward the increased utilization of technologically advanced processes. Companies operating in this sector are embracing sophisticated processes to maintain their market standing. For instance, in March 2022, WuXi Advanced Therapies, a wholly-owned subsidiary of the China-based biopharmaceutical company WuXi AppTec, launched its Tetracycline-Enabled Self-Silencing Adenovirus (TESSA) Technology. This advanced technology has enabled the approval of new therapies by simultaneously conducting all assay formulation, biosafety, viral clearance, product release, and testing internally. This method offers an innovative approach for producing adeno-associated virus (AAV) at Good Manufacturing Practices (GMP) grade without the need for transfection.

Which Key Market Players Are Investing In Expansion And Innovation Of Viral Inactivation Market?

Major companies operating in the viral inactivation market include Merck & Co. Inc., Sartorius AG, Texcell SA, SGS SA, Charles River Laboratories Inc., Clean Cells SAS, Rad Source Technologies, WuXi AppTec, Sigma-Aldrich Co. LLC, Thermo Fisher Scientific Inc., Macopharma, Cerus Corporation, TERUMO BCT INC., Shandong Weigao Group Medical Polymer Co. Ltd., Pall Corporation And Eurofins Scientific, General Electric Company, Cytiva, Mettler Toledo, Viral Inactivated Plasma Systems SA, Eurofins Scientific SE, Lonza Group AG, Avantor Inc., Bio-Rad Laboratories Inc., F. Hoffmann-La Roche AG, Fujifilm Holdings Corporation, Pfizer Inc., Novartis AG, Gilead Sciences Inc., Johnson & Johnson Private Limited

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/viral-inactivation-global-market-report

How Is Viral Inactivation Market Demand Varying Across Different Regions?

North America was the largest region in the viral inactivation market in 2024. Asia-pacific is expected to be the fastest-growing region in the global viral inactivation market during the forecast period. The regions covered in the viral inactivation market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Request A Customized Version Of The Viral Inactivation Market Report:

https://www.thebusinessresearchcompany.com/customise?id=10401&type=smp

Browse Through More Reports Similar to the Global Viral Inactivation Market 2025, By The Business Research Company

Viral Vectors And Plasmid Dna Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/viral-vectors-and-plasmid-dna-global-market-report

Antivirals Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/antivirals-global-market-report

Healthcare Personal Protective Equipment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/healthcare-personal-protective-equipment-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795